Jae Ha Lee is president and chief executive officer of CKP Therapeutics, and in charge of Korea operations. Dr. Lee has over 30 years of research and teaching experience as a professor at Sungkyunkwan University, University of Oklahoma, and Indiana University, spanning various topics, including valuation, M&A, IPOs, biotech investments, private equity, venture capital, corporate finance, and risk management.. He has served as advisor, committee chair, and board member for large companies and government agencies in the U.S. and Korea.  Dr. Lee received a Ph.D. in finance and an MBA from Indiana University.